Han Ying
Clinical trials sponsored by Han Ying, explained in plain language.
-
New drug combo shows promise for rare liver disease
Disease control OngoingThis study tests whether adding fenofibrate to the standard treatment (ursodeoxycholic acid) can improve liver health in people with primary biliary cholangitis (PBC), a chronic liver disease. About 184 adults aged 18-75 with PBC will take the combination and be monitored for cha…
Phase: PHASE2, PHASE3 • Sponsor: Han Ying • Aim: Disease control
Last updated May 02, 2026 17:01 UTC
-
New hope for liver patients: steroid combo trial targets Tough-to-Treat PBC
Disease control ENROLLING_BY_INVITATIONThis study looks at whether adding prednisone (a steroid) to the standard medicine UDCA can help people with primary biliary cholangitis (PBC) who also have moderate-to-severe interface hepatitis. About 244 adults aged 18-75 with this condition will take part. The goal is to see …
Phase: PHASE2, PHASE3 • Sponsor: Han Ying • Aim: Disease control
Last updated Apr 29, 2026 15:01 UTC